Aerocrine AB announced that Health Care Service Corp. will begin covering FeNO testing for asthma diagnosis and management effective April 1. According to a release, Aerocrine has received ...
Seven out of ten asthmatic patients report that cold air exacerbates their symptoms, according to research. As winter approaches, it is vital to plan for asthma control in advance. 1 Recommended by ...
The Fractional Exhaled Nitric Oxide (FeNO) test has long been part of clinical guidelines and was a key element in the previous asthma care recommendations from the National Institute for Health and ...
Rochester, MN, December 21, 2017 - Although about 24 million Americans are diagnosed with asthma every year, there is no single test that can diagnose the disease. Common symptoms, such as shortness ...
Aerocrine AB has announced that Health Care Service Corp. will begin covering FeNO testing for asthma diagnosis and management effective April 1. In a release, the Company said that it has received ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Circassia Inc. announced today that it has successfully engaged with major primary care national sales partners to expand the distribution of NIOX VERO®, its FeNO ...
Hosted on MSN
New data highlights urgent need for better asthma care – How FeNO testing can help reduce hospitalizations
Research from Asthma + Lung UK has found a significant rise in Accident and Emergency (A&E) visits from people experiencing breathing issues such as asthma. Asthma + Lung UK is a British charity ...
Nov. 17, 2021 – In its latest clinical practice guideline on evaluation and treatment of asthma, an American Thoracic Society expert guidelines panel has addressed the use of fractional exhaled nitric ...
Individuals with severe type 2 asthma and chronic rhinosinusitis with nasal polyps may benefit from the biologic treatment, dupilumab. A study on the efficacy of the biologic drug, dupilumab, found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results